These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30646433)

  • 1. [The Framework for Clinical Practice : Current Trends. Topics : II. Cost effectiveness analysis: impact on practice].
    Fukuda T
    Nihon Naika Gakkai Zasshi; 2016 Dec; 105(12):2330-2335. PubMed ID: 30646433
    [No Abstract]   [Full Text] [Related]  

  • 2. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of illness in cost-effectiveness analysis. A review of the methodology.
    Hodgson TA
    Pharmacoeconomics; 1994 Dec; 6(6):536-52. PubMed ID: 10155283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
    Khoudigian-Sinani S; Kowal S; Suggett JA; Coppolo DP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3065-3073. PubMed ID: 29089755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel on cost-effectiveness in health and medicine recommendations: identifying costs.
    Manning WG
    J Clin Psychiatry; 1999; 60 Suppl 3():54-6; discussion 57-8. PubMed ID: 10073379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cost effectiveness analyses in orthopaedic surgery.
    Brauer CA; Neumann PJ; Rosen AB
    Clin Orthop Relat Res; 2007 Apr; 457():42-8. PubMed ID: 17242614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
    O'Donnell MP; Roizen MF
    Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical objections against including life-extension costs in cost-effectiveness analysis: a consistent approach.
    Gandjour A; Müller D
    Appl Health Econ Health Policy; 2014 Oct; 12(5):471-6. PubMed ID: 25027546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can care for depression become more cost-effective?
    Sturm R; Wells KB
    JAMA; 1995 Jan; 273(1):51-8. PubMed ID: 7996651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a guideline for low back pain management in primary care: a cost-effectiveness analysis.
    Becker A; Held H; Redaelli M; Chenot JF; Leonhardt C; Keller S; Baum E; Pfingsten M; Hildebrandt J; Basler HD; Kochen MM; Donner-Banzhoff N; Strauch K
    Spine (Phila Pa 1976); 2012 Apr; 37(8):701-10. PubMed ID: 21738095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unequal discounting of health care costs and effects causes confusion].
    van Ballegooijen M; de Kok IM; Habbema JD
    Ned Tijdschr Geneeskd; 2010; 154():A1970. PubMed ID: 20619050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value.
    Pearson SD
    Value Health; 2018 Mar; 21(3):258-265. PubMed ID: 29566831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced topics in evidence-based urologic oncology: economic analysis.
    Vogel B; Gilbert SM; Boylston Herndon J; Dahm P
    Urol Oncol; 2011; 29(4):454-61. PubMed ID: 21726796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making the case for cost-effectiveness research.
    Abbott DE; Sutton JM; Edwards MJ
    J Surg Oncol; 2014 May; 109(6):509-15. PubMed ID: 24374952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-inclusive evaluation: a banquet of approaches for including costs, benefits, and cost-effectiveness and cost-benefit analyses in your next evaluation.
    Yates BT
    Eval Program Plann; 2009 Feb; 32(1):52-4. PubMed ID: 18977532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States.
    Rothschild MI; Russ R; Brennan KA; Williams CJ; Berrones D; Patel B; Martinez-Castellanos MA; Fernandes A; Hubbard GB; Chan RVP; Yang Z; Olsen TW
    Am J Ophthalmol; 2016 Aug; 168():110-121. PubMed ID: 27130372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early health economic modelling of single-stage cartilage repair. Guiding implementation of technologies in regenerative medicine.
    de Windt TS; Sorel JC; Vonk LA; Kip MMA; Ijzerman MJ; Saris DBF
    J Tissue Eng Regen Med; 2017 Oct; 11(10):2950-2959. PubMed ID: 27401932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.